MENU
SEP 17, 2020 Opens: 5:30 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Coronavirus Virtual Webinar Series

A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health Organization (WHO) as COVID-19. LabRoots will be working to educate the community about this pathogen in an ongoing series of webinars.

The First and Second Events of our Coronavirus Virtual Webinar Series were a great success! It is now available for on-demand viewing. Our next set of webinars will go live on September 17th.

This virus is a member of the coronavirus family and is zoonotic, or transmissible from animals to humans, and is thought to have originated in bats like other coronaviruses. Researchers are working to learn more about how this virus made the jump from animals to humans, probably through an intermediate species.

The COVID-19 virus has already infected tens of thousands of people worldwide. In China, hundreds have been killed, leading the World Health Organization to declare an international health emergency, one of only four that have ever been declared.

Researchers have found evidence that the virus can be transmitted by people that don't have symptoms. Scientists are working to find ways to treat the fever, respiratory illness, cough, and breathing difficulties it causes.

You can learn more from this event about:

  • The Origins and Symptoms of COVID-19
  • Laboratory tests in COVID-19 Diagnosis
  • Prevention, Containment, and Treatment of CoVID-19 Cases

This free event does not require any travel, and will remain ongoing; webinars will continue to occur in the future as we find out more about this pathogen. The content will be available for unlimited, on-demand viewing. The global community will be able to interact using chat sessions and live-streaming. This seamless connectivity will be available on any desktop or mobile device so you can view, learn, and interact.

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the Coronavirus webinar series and virtual event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar series, you can earn 1 Continuing Education credit per presentation.

Use #LRcoronavirus to follow the conversation!


Speakers

Show Resources
You May Also Like
JUL 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUL 29, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Immuno-Oncology & Cancer Biology The rapid development of immuno-oncology therapies has transformed the cancer treatment landscape. Discovering safe, potent, and persistent immune cell p...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 1st Annua...
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots and the Cell Biology Planning Committee are please to announce the 4th Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
MAY 05, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 05, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce our 3rd Forensic Sciences Virtual Event on May 5, 2021. Join us for this free, one-day event on May 5th as we discuss DNA, chemistry, toxicology, digital fore...
Infographic

All you need to know about 2019 Novel Coronavirus (CoVID-19)

CoVID-19 is spreading with wildfire speed, to date, there are 215,565 of confirmed CoVID-19 cases and 8893 covid-19 related deaths in the world and these numbers are being updated constantly (view current outbreak status). Many countries, including the U.S, are now in a state of a public health emergency. There is no known medication or vaccine to this virus, and currently, the only measure of defense is social isolation and hand hygiene. Here is what we know so far about the CoVID-19 virus. Keep safe and make sure you follow the CDC guidelines.

Below are some fast facts about CoVID-19. To view the comprehensive and to-the-point infographic, click here

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

Agenda
  • Critical raw material for mRNA-based vaccine development
    JUN 17, 2020 4:30 PM PDT
    Andrius Kočevas
    Product Manager, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Patterns of Intrahost and Interhost variation in SARS-CoV-2
    JUN 17, 2020 4:30 PM PDT
    Todd Treangen
    Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
  • Accelerating vaccine development using a next generation microfluidic CE platform
    JUN 17, 2020 3:00 PM PDT
    Jeray Thelwell
    Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
    Sponsored By: PerkinElmer
  • COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells
    JUN 17, 2020 3:00 PM PDT
    Marcello Stein, PhD
    Global Product Manager and Group Leader Immunology T cells
    Sponsored By: Miltenyi Biotec
  • Surgery as (Un)Usual: Development of Rodent Intracerebroventricular injection Capabilities During COVID-19
    JUN 17, 2020 3:00 PM PDT
    Matthew Flegal, BS, SRS
    Senior Manager InVivo Sciences, Charles River
  • JUN 17, 2020 1:30 PM PDT
    Sponsored By: Codex DNA
    Krishna Kannan, PhD
    Staff Scientist
    Katie Lyons, MS
    Sr. Scientist
  • JUN 17, 2020 1:30 PM PDT
    Sponsored By: NanoString Technologies
    Joseph M. Beechem, PhD
    CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of R...
    Christopher E. Mason, PhD
    Associate Professor of Genomics, Physiology, and Biophy...
    Robert Schwartz, PhD
    Assistant Professor of Medicine and of the Department o...
  • Will we have a vaccine for COVID-19? 5 reasons for optimism!
    JUN 17, 2020 1:30 PM PDT
    Rob Kozak, PhD FCCM
    Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • Will we have a vaccine for COVID-19? 5 reasons for optimism!
    JUN 17, 2020 1:30 PM PDT
    Rob Kozak, PhD FCCM
    Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • High-Throughput Assay for Monitoring COVID19 Antibodies and Their Isotypes
    JUN 17, 2020 12:00 PM PDT
    Susan Zolla-Pazner, PhD
    Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
    Sponsored By: LUMINEX
  • JUN 17, 2020 12:00 PM PDT
    Sponsored By: LUMINEX
    Aaron P. Benfield, PhD
    Senior Director, Molecular Applications
    Sherry A. Dunbar, PhD, MBA
    Senior Director, Global Scientific Affairs
  • JUN 17, 2020 12:00 PM PDT
    Klaus Hochleitner, PhD
    Global Technology Lead, Diagnostics, Cytiva
    Brendan O'Farrell, PhD
    President and Co-Founder, DCN Diagnostics
    Darren Rowles
    President and CEO, Sona Nanotech
    David Wilson
    Commercial Director, Diagnostics, Avacta Life Sciences
    Moderator: Lee Jenkins
    Senior Product Leader, Cytiva
  • JUN 17, 2020 10:30 AM PDT
    Sponsored By: LUMINEX
    Haley R. Pugsley, PhD
    Manager, Senior Scientist
    Kamala Tyagarajan, PhD
    Director, Flow Cytometry Assays & Application
  • Sleep Better Without Testing Nightmares: Critical Considerations When Choosing an RT-PCR Assay for SARS-CoV-2 Testing
    JUN 17, 2020 10:30 AM PDT
    Arvind Kothandaraman
    General Manager, Specialty Diagnostics
    Sponsored By: PerkinElmer
  • Strategies and Challenges for COVID-19 Antibody Development
    JUN 17, 2020 10:30 AM PDT
    Jiahui Yang, PhD
    Director, R&D, Sino Biological
    Sponsored By: Sino Biological, Inc.
  • Keynote Presentation: Another New Coronavirus?: The Coronaviruses of the 21st Century
    JUN 17, 2020 9:00 AM PDT
    Stephen S. Morse, PhD, FAAM, F.A.C.E.
    Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
  • JUN 17, 2020 7:30 AM PDT
    Sponsored By: Fluidigm
    Joel Guthridge, PhD
    Assistant Member, Arthritis and Clinical Immunology Dir...
    Petter Brodin, MD, PhD
    Associate Professor and consultant physician Science fo...
  • Development of Luminex Based Serological Test for COVID-19 Diagnosis and Monitoring
    JUN 17, 2020 7:30 AM PDT
    Imad Tarhoni, MD, PhD
    Postdoctoral Fellow at Rush University Medical Center in Chicago
    Sponsored By: LUMINEX
  • JUN 17, 2020 7:30 AM PDT
    Gabriel Fernandez de Pierola
    General Manager - Genomics & Diagnostic Solutions Cyti...
    Christopher Norey, PhD
    R&D Leader, Cytiva (formerly GE Healthcare Life Science...
  • Enhanced, rapid NGS tools for viral research
    JUN 17, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • JUN 17, 2020 6:00 AM PDT
    Sponsored By: LUMINEX
    Steve Angeloni
    Senior Field Applications Scientist, Luminex
    Nicole Pecora, MD, PhD
    Assistant Professor in Pathology and Laboratory Medicin...
  • Role of serology in the next phase of COVID-19 investigation and response
    JUN 17, 2020 6:00 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    Sponsored By: GenScript
  • Coronavirus Webinar Series; Understanding Diagnostic Modalities for SARS-CoV-2
    Jamie Evelyn Phillips, MS, PhD
    Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
  • Setting up a Coronavirus (COVID-19) Clinical Diagnostic Testing Lab? LIMS for Automation and Data Management
    Shonali Paul, MBA
    Chief Operating Officer, CloudLIMS.com
  • APR 02, 2020 2:30 PM PDT
    Sponsored By: BGI Americas,
    MGI Americas
    SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
    Pan Zhang, PhD
    Laboratory Director at BGI
  • Opportunities for using PacBio Long-read Sequencing for COVID-19 Research
    APR 02, 2020 2:30 PM PDT
    Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Sponsored By: PacBio
  • APR 02, 2020 1:00 PM PDT
    Jason Chen, MD
    Head of Virology Unit of KingMed Diagnostics
    Yushen Jiang, MD
    Deputy Director of Central Lab of DIAN Diagnostics
    Ruben Luo, PhD
    NACCCA Board Secretary, Clinical Fellow of UC San Franc...
    Chengbin Wang, MD
    Chairman of Chinese Society of Laboratory Medicine, Dir...
    Frank Yang, MD, PhD
    Pathologist (ABP-AP/CP, Hem), Vice President of ADICON...
  • Rapid Response to the Coronavirus Outbreak: How Collaboration Meets the Challenge
    APR 02, 2020 1:00 PM PDT
    Geert Koene, PhD
    Biosearch Technologies Market Segment Manager MDx, LGC
    Sponsored By: Biosearch Technologies
  • APR 02, 2020 11:30 AM PDT
    Sponsored By: GenScript
    Manzhu Kang, PhD
    Senior Scientist of Antibody Research Group at GenScrip...
    Sean Taylor
    Manager of the Field Applications Group at GenScript US...
  • Implementation of Molecular Diagnostics for SARS-CoV-2
    APR 02, 2020 11:30 AM PDT
    Li Jiang, MD, PhD
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • Laboratory Tests for CoVID-19
    APR 02, 2020 10:00 AM PDT
    Jun Wu, PhD
    Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • SARS-CoV-2 (CoVID-19: Emergence, Biology,  and Countermeasures)
    APR 02, 2020 10:00 AM PDT
    Mark R. Denison, MD
    Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
    Continuing Education: Florida CE | P.A.C.E. CE
  • Laboratory Diagnosis of SARS-CoV-2 Infections: Current Status
    APR 02, 2020 8:30 AM PDT
    Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
    APR 02, 2020 8:30 AM PDT
    Anupam Singhal
    Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
    Sponsored By: Berkeley Lights
  • COVID-19: Putting together the pieces of the pandemic
    APR 02, 2020 7:30 AM PDT
    Rowshanak Hashemiyoon, PhD
    Clinical Scientist, Author, Consultant
  • From Hendra to Wuhan: emerging bat-borne viruses in a quarter of century
    APR 02, 2020 7:30 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • APR 02, 2020 6:00 AM PDT
    Sponsored By: Fluidigm
    Bill Hunt, MS
    Director, Microfluidics Product Management, Fluidigm
    Andrew Quong, PhD
    Chief Science Officer, Fluidigm
  • Enhanced. Rapid Target Identification by NGS for Vaccine Development
    APR 02, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Laboratory tests in CoVID-19 diagnosis and treatment
  • Enhanced. Rapid Target Identification by NGS for Vaccine Development
    APR 02, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Laboratory Diagnosis of SARS-CoV-2 Infections: Current Status
    APR 02, 2020 8:30 AM PDT
    Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • Laboratory Tests for CoVID-19
    APR 02, 2020 10:00 AM PDT
    Jun Wu, PhD
    Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • Implementation of Molecular Diagnostics for SARS-CoV-2
    APR 02, 2020 11:30 AM PDT
    Li Jiang, MD, PhD
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • APR 02, 2020 11:30 AM PDT
    Sponsored By: GenScript
    Manzhu Kang, PhD
    Senior Scientist of Antibody Research Group at GenScrip...
    Sean Taylor
    Manager of the Field Applications Group at GenScript US...
  • APR 02, 2020 1:00 PM PDT
    Jason Chen, MD
    Head of Virology Unit of KingMed Diagnostics
    Yushen Jiang, MD
    Deputy Director of Central Lab of DIAN Diagnostics
    Ruben Luo, PhD
    NACCCA Board Secretary, Clinical Fellow of UC San Franc...
    Chengbin Wang, MD
    Chairman of Chinese Society of Laboratory Medicine, Dir...
    Frank Yang, MD, PhD
    Pathologist (ABP-AP/CP, Hem), Vice President of ADICON...
  • Opportunities for using PacBio Long-read Sequencing for COVID-19 Research
    APR 02, 2020 2:30 PM PDT
    Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Sponsored By: PacBio
  • APR 02, 2020 2:30 PM PDT
    Sponsored By: BGI Americas,
    MGI Americas
    SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
    Pan Zhang, PhD
    Laboratory Director at BGI
  • Prevention, Containment and Treatment of CoVID-19 Cases
  • APR 02, 2020 6:00 AM PDT
    Sponsored By: Fluidigm
    Bill Hunt, MS
    Director, Microfluidics Product Management, Fluidigm
    Andrew Quong, PhD
    Chief Science Officer, Fluidigm
  • Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
    APR 02, 2020 8:30 AM PDT
    Anupam Singhal
    Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
    Sponsored By: Berkeley Lights
  • SARS-CoV-2 (CoVID-19: Emergence, Biology,  and Countermeasures)
    APR 02, 2020 10:00 AM PDT
    Mark R. Denison, MD
    Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
    Continuing Education: Florida CE | P.A.C.E. CE
  • Rapid Response to the Coronavirus Outbreak: How Collaboration Meets the Challenge
    APR 02, 2020 1:00 PM PDT
    Geert Koene, PhD
    Biosearch Technologies Market Segment Manager MDx, LGC
    Sponsored By: Biosearch Technologies
  • The Origins and Symptoms of CoVID-19
  • From Hendra to Wuhan: emerging bat-borne viruses in a quarter of century
    APR 02, 2020 7:30 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • COVID-19: Putting together the pieces of the pandemic
    APR 02, 2020 7:30 AM PDT
    Rowshanak Hashemiyoon, PhD
    Clinical Scientist, Author, Consultant
  • Setting up a Coronavirus (COVID-19) Clinical Diagnostic Testing Lab? LIMS for Automation and Data Management
    Shonali Paul, MBA
    Chief Operating Officer, CloudLIMS.com
  • Coronavirus Webinar Series; Understanding Diagnostic Modalities for SARS-CoV-2
    Jamie Evelyn Phillips, MS, PhD
    Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
  • Enhanced, rapid NGS tools for viral research
    JUN 17, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Role of serology in the next phase of COVID-19 investigation and response
    JUN 17, 2020 6:00 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    Sponsored By: GenScript
  • JUN 17, 2020 6:00 AM PDT
    Sponsored By: LUMINEX
    Steve Angeloni
    Senior Field Applications Scientist, Luminex
    Nicole Pecora, MD, PhD
    Assistant Professor in Pathology and Laboratory Medicin...
  • JUN 17, 2020 7:30 AM PDT
    Gabriel Fernandez de Pierola
    General Manager - Genomics & Diagnostic Solutions Cyti...
    Christopher Norey, PhD
    R&D Leader, Cytiva (formerly GE Healthcare Life Science...
  • JUN 17, 2020 7:30 AM PDT
    Sponsored By: Fluidigm
    Joel Guthridge, PhD
    Assistant Member, Arthritis and Clinical Immunology Dir...
    Petter Brodin, MD, PhD
    Associate Professor and consultant physician Science fo...
  • Development of Luminex Based Serological Test for COVID-19 Diagnosis and Monitoring
    JUN 17, 2020 7:30 AM PDT
    Imad Tarhoni, MD, PhD
    Postdoctoral Fellow at Rush University Medical Center in Chicago
    Sponsored By: LUMINEX
  • Keynote Presentation: Another New Coronavirus?: The Coronaviruses of the 21st Century
    JUN 17, 2020 9:00 AM PDT
    Stephen S. Morse, PhD, FAAM, F.A.C.E.
    Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
  • JUN 17, 2020 10:30 AM PDT
    Sponsored By: LUMINEX
    Haley R. Pugsley, PhD
    Manager, Senior Scientist
    Kamala Tyagarajan, PhD
    Director, Flow Cytometry Assays & Application
  • Strategies and Challenges for COVID-19 Antibody Development
    JUN 17, 2020 10:30 AM PDT
    Jiahui Yang, PhD
    Director, R&D, Sino Biological
    Sponsored By: Sino Biological, Inc.
  • Sleep Better Without Testing Nightmares: Critical Considerations When Choosing an RT-PCR Assay for SARS-CoV-2 Testing
    JUN 17, 2020 10:30 AM PDT
    Arvind Kothandaraman
    General Manager, Specialty Diagnostics
    Sponsored By: PerkinElmer
  • JUN 17, 2020 12:00 PM PDT
    Sponsored By: LUMINEX
    Aaron P. Benfield, PhD
    Senior Director, Molecular Applications
    Sherry A. Dunbar, PhD, MBA
    Senior Director, Global Scientific Affairs
  • JUN 17, 2020 12:00 PM PDT
    Klaus Hochleitner, PhD
    Global Technology Lead, Diagnostics, Cytiva
    Brendan O'Farrell, PhD
    President and Co-Founder, DCN Diagnostics
    Darren Rowles
    President and CEO, Sona Nanotech
    David Wilson
    Commercial Director, Diagnostics, Avacta Life Sciences
    Moderator: Lee Jenkins
    Senior Product Leader, Cytiva
  • High-Throughput Assay for Monitoring COVID19 Antibodies and Their Isotypes
    JUN 17, 2020 12:00 PM PDT
    Susan Zolla-Pazner, PhD
    Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
    Sponsored By: LUMINEX
  • JUN 17, 2020 1:30 PM PDT
    Sponsored By: NanoString Technologies
    Joseph M. Beechem, PhD
    CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of R...
    Christopher E. Mason, PhD
    Associate Professor of Genomics, Physiology, and Biophy...
    Robert Schwartz, PhD
    Assistant Professor of Medicine and of the Department o...
  • Will we have a vaccine for COVID-19? 5 reasons for optimism!
    JUN 17, 2020 1:30 PM PDT
    Rob Kozak, PhD FCCM
    Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • Will we have a vaccine for COVID-19? 5 reasons for optimism!
    JUN 17, 2020 1:30 PM PDT
    Rob Kozak, PhD FCCM
    Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • JUN 17, 2020 1:30 PM PDT
    Sponsored By: Codex DNA
    Krishna Kannan, PhD
    Staff Scientist
    Katie Lyons, MS
    Sr. Scientist
  • COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells
    JUN 17, 2020 3:00 PM PDT
    Marcello Stein, PhD
    Global Product Manager and Group Leader Immunology T cells
    Sponsored By: Miltenyi Biotec
  • Surgery as (Un)Usual: Development of Rodent Intracerebroventricular injection Capabilities During COVID-19
    JUN 17, 2020 3:00 PM PDT
    Matthew Flegal, BS, SRS
    Senior Manager InVivo Sciences, Charles River
  • Accelerating vaccine development using a next generation microfluidic CE platform
    JUN 17, 2020 3:00 PM PDT
    Jeray Thelwell
    Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
    Sponsored By: PerkinElmer
  • Critical raw material for mRNA-based vaccine development
    JUN 17, 2020 4:30 PM PDT
    Andrius Kočevas
    Product Manager, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Patterns of Intrahost and Interhost variation in SARS-CoV-2
    JUN 17, 2020 4:30 PM PDT
    Todd Treangen
    Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
Speakers

  • Steve Angeloni
    Senior Field Applications Scientist, Luminex
    Biography
      Dr. Angeloni has over 25 years of research and industry experience with the development of a wide variety of biochemical, genetic, proteomic, immunology, microscopy, cellular and molecular biology assays. These technologies were applied to studying genetic and environmental factors contributing to the susceptibility or resistance to a number of infectious and non-infectious diseases. This includes studies on disease mechanisms or treatments in the areas of endocrinology, cancer, obesity, diabetes and the development of DNA vaccines. These research efforts employed cellular, mouse and non-human primate model systems. This diversified experience has been applied to developing and supporting commercial applications for cellular genetic engineering, bioinformatic data analysis as well the development of genomic and proteomic assay platforms for research and diagnostics. This experience is now available for supporting the research efforts of Luminex customers for all their custom assay needs.
    • Meredith Ashby, PhD
      Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
      Biography
        Meredith Ashby is the Director of Market Strategy for Microbial Genomics, Cancer and Immunology at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced. Inspired by the impact of genome sequencing on her research, she joined PacBio after a postdoc at UCSF. She has been with the company since 2009 and has worked in R&D on both sequencing optimization and bioinformatics application development. She is now focused on facilitating the use of PacBio long read sequencing to solve the unmet needs of scientists seeking to understand the incredibly diverse range of microbes that live in, on and around us and the systems we depend on.
      • Joseph M. Beechem, PhD
        CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES
        Biography
          Joe Beechem joined NanoString in 2012 as the Senior Vice President of Research and Development and is now also the company's Chief Scientific Officer. Dr. Beechem leads a multidisciplinary team at NanoString based in Seattle, WA where he and his colleagues develop innovative technology platforms and assays based on the company's nucleic-acid based optical barcodes for multiplexed quantification of biomolecules. He has become a scientific powerhouse for the company, co-inventing 3D Biology - the simultaneous profiling of DNA, RNA, and Protein on the nCounter® system - as well as the GeoMx® Digital Spatial Profiler (DSP), which affords highly-multiplexed and quantitative profiling of RNA and protein from tissue sections in user-defined geographic regions of interest. At NanoString, Dr. Beechem has played an integral role in bringing the Hyb and Seq™ chemistry to life, making NGS from FFPE sections without library prep a reality. Dr. Beechem is an author on over 150 peer-reviewed papers in diverse fields: biomathematics, physics, chemistry, physiology, spectroscopy, diagnostics, medicine and biology. He received a doctorate in Biophysics from The Johns Hopkins University and started his career as a tenure-track faculty member at Vanderbilt University. His varied skills were sought-after in industry; in 2004, he joined Invitrogen as their Chief Science/Technology Officer and quickly rose to become the Head of R&D, Advanced Sequencing Technologies.
        • Aaron P. Benfield, PhD
          Senior Director, Molecular Applications
          Biography
            Aaron Benfield has over 20 years experience in molecular biology applications within industrial, public health, and academic settings. He is currently the Senior Director of Molecular Applications at Luminex, where he leads a team of Molecular Application Specialists that perform product implementation of Luminex technology at diagnostic customer sites. Aaron is also involved in various aspects of customer development, scientific affairs, as well as marketing and sales activities. Prior to his current role, Aaron received his B.S. and Ph.D. in molecular biology from the University of Texas at Austin, studying the energetics of biomolecular structure. He then went on to be a National Institutes of Health Postdoctoral Fellow at the University of Texas/MD Anderson Cancer Research Center where he studied DNA damage and mutagenesis. Aaron then moved on to become the Molecular Biology Group Manager at the Texas Department of State Health Services, where he oversaw molecular testing for diagnostic and epidemiological purposes.
          • Petter Brodin, MD, PhD
            Associate Professor and consultant physician Science for Life Laboratory, Karolinska Institutet Department of Pediatric Rheumatology, Karolinska University Hospital, Stockholm
            Biography
              Petter Brodin is a pediatrician at the Karolinska University Hospital and an immunologist at Science for Life Laboratory (SciLifeLab). His lab combines state-of-the-art experimental methods and computational tools to monitor human immune systems as comprehensively as possible. Recently Dr. Brodin was appointed Swedish coordinator for the international COVID Human Genetic Effort consortium. Its goal is to search for possible inborn errors of immunity in patients who require intensive care for COVID-19 despite being younger than 50 and having no underlying health conditions.
            • Jason Chen, MD
              Head of Virology Unit of KingMed Diagnostics
            • Mark R. Denison, MD
              Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
              Biography
                Mark Denison M.D. is the Craig-Weaver Professor of Pediatrics, Pathology, Microbiology & Immunology at Vanderbilt University Medical Center in Nashville, TN. Dr. Denison has performed over 25 years of NIH-funded research focused on the replication, pathogenesis, and evolution of coronaviruses, a family of RNA viruses from which SARS-CoV emerged. Coronaviruses cause respiratory infections in humans and increasingly are thought to be ubiquitous among mammalian species. Notably, a large number of novel coronaviruses have been identified in bats, suggesting that bats may be critical for the emergence of coronaviruses in other species. Coronaviruses may have unique potential for cross-species movement. They encode novel RNA synthesis and probable RNA proofreading functions, thereby conferring the ability to maintain large and complex genomes and to respond to host or other environmental changes. The Denison lab focuses on determining the mechanisms of coronavirus evolution and host species movement and adaptation, using synthetic biology and reverse genetics. Dr. Denison has served on the steering committee for the Southeast Regional Center of Excellence in Emerging Infections and Biodefense for the past eight years. In addition, he is the Chair of the Vanderbilt Institutional Biosafety Committee and has served on multiple Government and international panels involved in review or consideration of biodefense, biosecurity, and synthetic biology.
              • Sherry A. Dunbar, PhD, MBA
                Senior Director, Global Scientific Affairs
                Biography
                  Dr. Dunbar received a B.S. degree in Microbiology and Immunology, and a MBA from the University of Maryland. She completed a Ph.D. in Medical Microbiology and Immunology from the University of South Alabama and a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She was then the clinical laboratory director at Virus Reference Laboratory in Houston, Texas. Dr. Dunbar joined Luminex as a Senior Scientist in 1999 and served as Senior Director of the Biology Research and Development group for eight years. This group developed assay protocols, techniques, and helped to determine the best practices for xMAP Technology. During this time, the laboratory developed more than one hundred multiplexed assay panels for proteins, nucleic acids and other biomolecules. Currently, Dr. Dunbar is the Senior Director of Global Scientific Affairs for Luminex. She has more than forty publications in the peer-reviewed literature and numerous abstracts presented at scientific conferences.
                • Gabriel Fernandez de Pierola
                  General Manager - Genomics & Diagnostic Solutions Cytiva (formerly GE Life Sciences)
                  Biography
                    Gabriel Fernandez de Pierola is the Genomics & Diagnostic Solutions General Manager at Cytiva, formerly GE Healthcare Life Sciences, since 2017. He is responsible for the development & commercialization of products & services that enable automatable, cost effective and reliable technologies for kit developers and end users mainly focus on Genomics. Previously he was the Global Commercial Finance manager for the GE Healthcare Bioprocess business. Gabriel started his career in the GE Capital Financial Management Program in 1999. Gabriel holds a Bachelor of Business Administration degree from ICADE (Spain) & Reims Management School (France).
                  • Matthew Flegal, BS, SRS
                    Senior Manager InVivo Sciences, Charles River
                    Biography
                      Matt entered the research field almost 30 years ago as a lab animal technician at the TSI/Mason contract research facility in Worcester, Massachusetts. Since then, he has worked in laboratory contract facilities such as Primedica and OREAD Biosafety, as well as within the biotech/pharma industry at Pharmacia, Pfizer, Genzyme/Sanofi-Aventis, and Biogen. Matt joined Charles River Laboratories last year as the senior manager of the In Vivo Sciences department at their Shrewsbury, Massachusetts facility. During his career, Matt has performed a variety of surgical procedures including device implantation, organ transplants, orthopedic defect, ocular and vascular implants, cardiac procedures, fibrosis modelling and brain and spinal procedures. His experience ranges from mice and rats to non-human primates and livestock. He holds patents for novel surgical devices and implants and has been training technicians, scientists, veterinarians, and physicians in surgical techniques and procedures for over 20 years. He is currently also an adjunct professor at the Worcester Polytechnic Institute, teaching the graduate-level Laboratory Animal Surgery course. Outside of the surgical realm, he has been a toxicology and pharmacology study director, cardiac sonographer, safety pharmacology scientist, and manager. Currently, Matt manages a team of over 70 technicians, trainers, data reviewers, team leaders, and supervisors. Matt served on the board of directors for the Academy of Surgical Research for over ten years, including as the program chair for three years and the educational chair for two years. He is the current president for the New England branch of AALAS.
                    • Dan Gibson, PhD
                      CTO
                      Biography
                        Dan Gibson is the CTO of Codex DNA. He oversees Codex DNA's world-class R&D team and sets the technical vision for the company. Dan is the inventor of the Gibson Assembly® method, which has over 4,000 citations in scientific literature, and is regarded as a luminary in the field of synthetic biology. He and his team are consistently pioneering new ways to advance the field of synthetic biology and pushing boundaries in the disciplines of personalized medicine, antibody therapy development, agriculture and industrial materials. Dan and his team formed the foundational technology that drives the BioXp 3200TM and the Digital to Biologic Converter (DBC) and continue to develop new, cutting edge tools for whole genome design, synthesis and assembly, and activation. To learn more about the work of Dan's team and the DBC view his 2018 Ted talk. Prior to Codex, Dan was Vice President of DNA Technology at Synthetic Genomics where he spearheaded efforts to develop a rapid approach for producing viral genes used in pandemic vaccine production in 2013, and he led the team that developed the first synthesized minimal cell in the world in 2016. Prior to Synthetic Genomics Dan spent more than six years at the J. Craig Ventner Institute where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010. Dr. Gibson earned his Ph.D. in Molecular Biology from the University of Southern California. Before earning his Ph.D., he earned his Bachelor's degree in Biological Sciences from the State University of New York at Buffalo.
                      • Joel Guthridge, PhD
                        Assistant Member, Arthritis and Clinical Immunology Director of Translational Informatics, Clinical Resources, Biorepository and Human Phenotyping Cores, Oklahoma Medical Research Foundation
                        Biography
                          Joel Guthridge, PhD is an Assistant Member of the Arthritis and Clinical Immunology Program at the Oklahoma Medical Research Foundation where his is also the Director of the Translational Informatics, Human Phenotyping and the CAP certified OMRF Biorepository. His research centers on mechanisms of lupus disease and understanding the molecular basis of the heterogeneity of lupus disease manifestations. Dr. Guthridge is the Co-PI of the Accelerating Medicines Partnership in SLE and RA, Tissue Resources Group as part of the AMP SLE/RA Leadership Center. The Human Phenotyping and Biorepository Cores at OMRF are also NIH funded through NIAMS Rheumatic Disease Resources Cores Center and NIGMS/IDeA Center for Research Translation funding. Dr. Guthridge's previous positions included management of the informatics and high-throughput screening groups at Univera Pharmaceuticals, Evolutionary Genomics and Dharmacon. Prior to this, he was an Instructor in the Department of Medicine, Division of Rheumatology at the University of Colorado Health Sciences Center with a focus on complement regulation and regulatory protein structure and function.
                        • Rowshanak Hashemiyoon, PhD
                          Clinical Scientist, Author, Consultant
                          Biography
                            Dr. Rowshanak Hashemiyoon is a clinical scientist, author, and consultant. Her work focuses on identifying the altered network dynamics underlying the dysfunctional brain states of neuropsychiatric and neurologic disorders, and fostering the development of novel treatments which alleviate the symptoms of these disorders. Dr. Hashemiyoon was the founder and head of the Human Brain and Behavior Laboratory in the Department of Stereotactic and Functional Neurosurgery at the University Hospital of Cologne in Germany, where she converged methods of computational neuroscience with clinical care in order to optimize neurosurgical patient outcomes. Dr. Hashemiyoon did her post-doctoral fellowship at the Yale University School of Medicine before taking a faculty position at the Center for Complex Systems at FAU in Florida. While at the University of Miami, she reported the first longitudinal study of the effects of deep brain stimulation on the underlying neuropathophysiology in a psychiatric disorder in humans. Her work described the dynamics of neuronal activation in correlation with the symptomatology observed in Tourette syndrome, offering important insights into tic genesis and expression.
                          • Klaus Hochleitner, PhD
                            Global Technology Lead, Diagnostics, Cytiva
                            Biography
                              Dr. Hochleitner is a cell and molecular biologist and has covered different roles in the field of membrane research and development, and developing diagnostic tests on solid surfaces. He is working in the field of lateral flow tests for more than 25 years.
                            • Bill Hunt, MS
                              Director, Microfluidics Product Management, Fluidigm
                              Biography
                                Bill Hunt is a Director of Microfluidics Product Management and has been with Fluidigm for four years. Prior to joining Fluidigm, he was a Marketing Director at Celera Corporation where he managed the commercial relationship with Abbott Molecular, Celera's global distribution partner. Bill earned both Bachelor and Master degrees in Genetics and Molecular Biology from the Pennsylvania State University.
                              • Li Jiang, MD, PhD
                                Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
                              • Yushen Jiang, MD
                                Deputy Director of Central Lab of DIAN Diagnostics
                              • Manzhu Kang, PhD
                                Senior Scientist of Antibody Research Group at GenScript ProBio
                                Biography
                                  Dr. Manzhu Kang received her Ph. D. from the University of California Los Angeles, with a dissertation focusing on the impact of combinatorial therapy on the evolution of drug resistance. Dr. Kang is a senior scientist of antibody research group at GenScript ProBio. She is in charge of the single B cell screening platform for antibody drug discovery
                                • Krishna Kannan, PhD
                                  Staff Scientist
                                  Biography
                                    Krishna Kannan is a Staff Scientist at Codex DNA. He received his PhD from the University of Illinois at Chicago. Over the past few years, Krishna has worked closely with Synthetic Biology experts at JCVI and SGI, and contributed to the development of synthetic cell with a minimal genome and the digital-to-biological converter. He recently completed the de novo synthesis of the SARS-CoV-2 genome. Krishna's research has been published in top tier journals such as PNAS, Cell, Science and Nature Biotechnology. In his current role, Krishna is involved in Codex DNA's new product development.
                                  • Cris Kinross
                                    Global Market Development, Thermo Fisher Scientific
                                    Biography
                                      Cris Kinross graduated in Neuroscience from Allegheny College, where she investigated the molecular role of stress and aging on brain resilience. Her focus on NGS development has contributed to the democratization and simplification of NGS technology.
                                    • Andrius Kočevas
                                      Product Manager, Thermo Fisher Scientific
                                      Biography
                                        Andrius Kočevas graduated from Vytautas Magnus University where he obtained a Master of Science in Molecular Biology and Biotechnology. Currently, Andrius leads the Molecular Biology Product Management team, which focuses on product customization and support of customers in diagnostic and therapeutic markets.
                                      • Geert Koene, PhD
                                        Biosearch Technologies Market Segment Manager MDx, LGC
                                        Biography
                                          Geert holds a PhD in immuno-oncology from Utrecht University, the Netherlands and has been active in MDx industry for over 15 years in various global roles. Joining LGC, Biosearch technologies 1.5 years ago, he oversees the strategic development for the MDx segment.
                                        • Arvind Kothandaraman
                                          General Manager, Specialty Diagnostics
                                          Biography
                                            Arvind Kothandaraman leads the specialty diagnostics business at PerkinElmer. His primary interest is in equipping clinical laboratories with the tools needed to meet their technical and operational goals. Prior to PerkinElmer, Arvind held positions at Thermo Fisher Scientific, BioReference Laboratories and Advanced Analytical Technologies. Arvind holds a Master's degree in Science and Business from the Claremont Colleges in California, USA.
                                          • Rob Kozak, PhD FCCM
                                            Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
                                            Biography
                                              Dr. Rob Kozak completed his PhD in microbiology and immunology at McGill University. Following this he pursued fellowships in viral hepatitis and zoonotic viruses at McGIll and the Ontario Veterinary College, University of Guelph, respectively. Dr Kozak also trained at the Special Pathogens Program at Canada's National Microbiology Laboratory in Winnipeg where he studied viral hemorrhagic fevers. He completed the clinical microbiology training program at the University of Toronto, and is a Fellow of the Canadian College of Microbiologists. He also serves on the boards of the Canadian College of Microbiologists and the Canadian Association of Clinical Microbiology and Infectious Diseases. He is clinical microbiologist at Sunnybrook Health Sciences Centre and an Associate professor in the department of laboratory medicine and pathobiology at the University of Toronto. His research program focuses on emerging viruses.
                                            • Ruben Luo, PhD
                                              NACCCA Board Secretary, Clinical Fellow of UC San Francisco
                                            • Katie Lyons, MS
                                              Sr. Scientist
                                              Biography
                                                Katie Lyons is a molecular and synthetic biologist at Codex DNA. She was responsible for adapting the synthetic gene assembly process onto the BioXpTM , the first instrument capable of "printing" genes. Katie has worked in protein and RNA vaccine engineering, molecular diagnostics at the San Diego Zoo Institute for Conservation Research and is currently a Senior Scientist at Codex DNA.
                                              • Christopher E. Mason, PhD
                                                Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
                                                Biography
                                                  Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y. He has >200 peer-reviewed papers and scholarly works that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as legal briefs cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He is an inventor on four patents, co-founded five biotechnology start-up companies, and serves as an advisor to many others. He lives with his daughter and wife in Brooklyn, NY.
                                                • Stephen S. Morse, PhD, FAAM, F.A.C.E.
                                                  Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
                                                  Biography
                                                    Stephen S. Morse, Ph.D., is Professor of Epidemiology at the Columbia University Mailman School of Public Health, where he also serves as Director of the Infectious Disease Epidemiology certificate and as chair of the Columbia University Institutional Biosafety Committee (IBC). He was founding Director of the CDC-funded "Center for Public Health Preparedness" (2000-2005). Before coming to Columbia, Dr. Morse was Assistant Professor (virology) in The Rockefeller University (1985-1995), and Program Manager for Biodefense at DARPA (the Defense Advanced Research Projects Agency) from 1995 to 2000. He was appointed in 2014 to the U.S. government's National Science Advisory Board for Biosecurity (NSABB). His research interests focus on infectious disease surveillance, and the epidemiology and assessment of emerging infectious diseases, including influenza. He was Chair of the NIH "Conference on Emerging Viruses" (1989), for which he originated the concept of emerging viruses/infections, was founding chair of ProMED (the Program to Monitor Emerging Diseases, best known for originating outbreak reporting on the Internet in 1994); and served on the Institute of Medicine (now National Academy of Medicine) Committee on Emerging Microbial Threats to Health (1990-1992), and chaired its Virology Task Force. His book Emerging Viruses (Oxford University Press, 1993) was selected by American Scientist as one of "The Top 100 Science Books of the [20th] Century". He was a founding member of the National Academies' "Forum on Emerging Infections" (later renamed the "Forum on Microbial Threats"), a founding section editor of the CDC journal Emerging Infectious Diseases, former Editor-in-Chief of the Pasteur Institute's virology journal, and global co-Director of PREDICT (a USAID project to strengthen global capacity for surveillance and detection of new infectious disease threats) from 2009 to 2014. He is currently an Associate Editor of Disaster Medicine & Public Health Preparedness, and serves on the Editorial Board of several journals, including Health Security and Viral Immunology. He also serves on committees at the National Academies of Sciences and the World Health Organization (WHO), including the WHO Expert Group on Pandemic Influenza Preparedness Planning in the Eastern Mediterranean Region. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Academy of Microbiology, the American College of Epidemiology, the New York Academy of Medicine, the New York Academy of Sciences (and was Chair of its Microbiology Section), and other professional societies, and is a Life Member of the Council on Foreign Relations. He received his Ph.D. (in microbiology) from the University of Wisconsin-Madison.
                                                  • Subodh Nimkar
                                                    Senior Product Manager, Complete Genomics Facility, MGI
                                                    Biography
                                                      Subodh Nimkar is a Senior Product Manager in MGI based in Complete Genomics facility in San Jose CA. His primary responsibilities include management and commercialization of the novel CoolMPS Chemistry for Massively Parallel Sequencing on DNBSEQ platforms. He is also responsible for product management and commercialization of MGIs sequencing solutions in AMERICAS. Over last 20 years he has worked with ABI, Thermo Fisher, Agilent and Streck. He has authored two key patents at ABI and commercialized solutions based on that. He holds a Masters in Chemical Engineering and MBA.
                                                    • Christopher Norey, PhD
                                                      R&D Leader, Cytiva (formerly GE Healthcare Life Sciences)
                                                      Biography
                                                        Dr. Chris Norey is an R&D Leader with over 25 years experience in the Life Sciences industry afer gaining a PhD in Biochemistry and Molecular Biology. For the past 10 years Dr Norey has lead teams responsible for launching over 25 new products, including instrumentation and reagent and consumable products, most recently the Sera-XtractaTM genomic and cell free nucleic acid isolation kits. He currently leads the Genomics R&D team at Cytiva focussed on delivering tools for the growing field of genetic based diagnostic applications.
                                                      • Brendan O'Farrell, PhD
                                                        President and Co-Founder, DCN Diagnostics
                                                        Biography
                                                          Dr O'Farrell has worked in the rapid diagnostics field for over 25 years and has been involved in over 200 product development programs in that time. He has wide experience in the development, manufacturing and commercialization of rapid diagnostics in a variety of industry verticals. In 2005 he co-founded DCN Diagnostics, a market leading provider of contract development and manufacturing services to the rapid diagnostics business, where is holds the role of President.
                                                        • Shonali Paul, MBA
                                                          Chief Operating Officer, CloudLIMS.com
                                                          Biography
                                                            Shonali is the Chief Operating Officer at CloudLIMS.com. In a career spanning over twenty years, Shonali Paul has built a long and impressive track record of success in high technology bioinformatics workflow solutions, strategic collaborations, developing operational strategy, and directing new business initiatives from conception through execution. She has helped build the research and development center and is the key driver of the product and scientific teams. She has been extensively published in journals such as Biopreservation and Biobanking (BIO) and Lab Manager and has given numerous talks at ISBER, ESBB, and Labroots. She has been a member of the marketing committee and the IT working group and is now the chair of the Member Relations Committee at ISBER, the International Society for Biological and Environmental Repositories.
                                                          • Nicole Pecora, MD, PhD
                                                            Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY
                                                            Biography
                                                              Nicole Pecora got her MD and PhD from Case Western Reserve University in Cleveland Ohio where she focused on host/pathogen interactions in Tuberculosis. She completed her residency in clinical pathology and fellowship in medical microbiology at Brigham and Women's Hospital in Boston MA. She is currently an Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY where she is also the Associate Director of Clinical Microbiology. In this role she has overseen both molecular and serological diagnostics for COVID-19.
                                                            • Jamie Evelyn Phillips, MS, PhD
                                                              Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
                                                              Biography
                                                                Jamie obtained her Masters and PhD from the University of Georgia, in Infectious Diseases. During her graduate studies she focused on Coronavirus viral genome annotation and identification of genes associated with pathogenicity. In between her Masters and PhD program she spent time in Ghana aiding the Ministry of Health with developing a vaccine program for women and children. Following her graduate studies, she held a two-year postdoctoral position serving as the primary molecular virologist in a small diagnostic lab, while concurrently serving as an Associate professor of biology at Georgia Gwinnett College (GGC). At GGC she taught a microbiology lab and lecturer. In the diagnostic lab she utilized primary virus isolation, serum neutralization assays, and real time PCR to investigate the origin of outbreaks and the evolution of the pathogens. After her postdoctoral position, she held a brief research associate position at the University of California Davis (UC Davis) where she aided in validating diagnostic assays and looking at the role co-infections play with influenza viruses. She left UC Davis for a small biotech company located in southern California looking to relocate to Eatonton, Ga. In 2014, Jamie joined Aalto Scientific, where she served as the Director of Research. Aalto Scientific is a privately owned manufacturer of control and calibration material for clinical chemistry analyzers. During her time there she oversaw the Research and Development department's relocation serving as the primary source of knowledge transfer for all open design control projects. Due to the relocation, she was able to hire an entire R&D team that was successful in transferring more than five projects to production and two of these projects receiving FDA 510K clearance. This position enabled her to obtain a broad knowledge of clinical chemistry lab analyzers and point of care test (POC). During her time at Aalto she also enjoyed giving back by giving industry guest lectures for the BioChemical Engineering Program at UGA. In 2017, Jamie joined Roche Diagnostics in their Medical and Scientific Affairs Division in Fishers, Indiana supporting their molecular POC devices. In this current role she oversees the Medical Plan and investigator initiated studies associated with the cobas Liat, a CLIA waived molecular POC device. Additionally, she currently serves as a subject matter expert for respiratory pathogens and antimicrobial stewardship initiatives.Starting in early January, Jamie joined Roche's Emergency Response team and has been playing an integral role, from a scientific perspective, on the launch of Roche's SARS-CoV-2 diagnostics assays.
                                                              • Haley R. Pugsley, PhD
                                                                Manager, Senior Scientist
                                                                Biography
                                                                  Haley R. Pugsley, Ph.D., is a Manager, Senior Scientist for the Amnis Flow Cytometry products at Luminex Corporation. Haley received her Ph.D. in Analytical Chemistry from the University of Washington working under the direction of Professor Norman J. Dovichi. At the University of Washington she used capillary electrophoresis to study protein fingerprinting of breast cancer tissue and created two reporter cell lines to investigate the expression of RecA in Deinococcus radiodurans. Dr. Pugsley did her postdoctoral fellowship at Hematologics, Inc. under the direction of Dr. Michael R. Loken where she focused on clinical flow cytometry and its use in diagnosing hematologic malignancies. Dr. Pugsley joined Amnis (now part of Luminex Corporation) in 2011 developing applications for the ImageStreamX Mk II, FlowSight and CellStream flow cytometers. During her time at Luminex Corporation, Dr. Pugsley has worked on many applications including autophagy, immunological synapse, algae biomass, cell signaling, and most recently extracellular vesicles.
                                                                • Andrew Quong, PhD
                                                                  Chief Science Officer, Fluidigm
                                                                  Biography
                                                                    Andrew Quong joined Fluidigm's executive team as Chief Science Officer in June 2019. Prior to this, Andrew was the Director of Strategic Scientific Initiatives and Partnerships at the Frederick National Laboratory for Cancer Research, a federally funded research and development center sponsored by the National Cancer Institute. Frederick National Laboratory is at the forefront of basic, translational and clinical science with a focus on cancer, AIDS and infectious disease. Prior to joining the Frederick National Laboratory, Quong served as a faculty member in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University.
                                                                  • Darren Rowles
                                                                    President and CEO, Sona Nanotech
                                                                    Biography
                                                                      A commercially-minded scientist, Darren joined Sona after 14 years' experience in the diagnostic and nanoparticle industry. He previously worked for one of the leading providers of technologies to the global diagnostics market, where he specialised in product manufacture and development in the area of noble metal nanoparticles and lateral flow diagnostics. Darren is a key opinion leader at industry seminars and conferences and acts as an advisory board member to the World Gold Council. Darren has a BSC in Biomedical Science and Toxicology from University of Wales Institute Cardiff and a Master of Business Administration from University of Bath.
                                                                    • Robert Schwartz, PhD
                                                                      Assistant Professor of Medicine and of the Department of Physiology, and Biophysics, and Systems Biology, Weill Cornell Medicine
                                                                      Biography
                                                                        Dr. Robert Schwartz is an Assistant Professor of Medicine and of the Department of Physiology, and Biophysics, and Systems Biology at Weill Cornell Medicine. He completed his Ph.D. in Biomedical Engineering at the University of Minnesota. His thesis work was on the derivation of stem cell derived hepatocytes and in vitro liver model systems. He completed his insternship and residency in Internal Medicine at Washington University in St. Louis/Barnes Jewish Hospital. His fellowship in Gastroenterology and Hepatology with a focus on hepatology was completed at the Brigham and Women's Hospital. He did a postdoc at MIT and his research continued to focus on the development of stem cell derived hepatocytes as a model system to study human liver disease and for clinical therapy. In his own lab at Weill Cornell Medical College he has continued to focus his work on the clinical translation and research applications of stem cell derived hepatocytes and primary human hepatocytes. In recognition of his work, he was an University of Minnesota Doctoral Dissertation Fellow, an AGA Research Scholar, a UEG Rising Scholar, a Bohmfalk Clinical Scholar, and an Irma Hirsch Trust Scholar. He has >50 peer-reviewed papers and scholarly works that have been featured in Nature, Cell, Nature Chemical Biology, Cell Stem Cell, Journal for Clinical Investigation, and Gastroenterology. He is an inventor on three patents.
                                                                      • Anupam Singhal
                                                                        Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
                                                                        Biography
                                                                          Anupam Singhal earned his PhD from the University of British Columbia and has over 15 years of experience in nanotechnology and microfluidics at UBC, the University of Toronto and Stanford University. His work has been cited over 600 times and resulted in several patents for molecular disease diagnosis, antibody discovery, and development of production cell-lines for biologics. At Berkeley Lights, Anupam leads the development of next-generation platforms for the discovery and development of antibody therapeutics.
                                                                        • Marcello Stein, PhD
                                                                          Global Product Manager and Group Leader Immunology T cells
                                                                          Biography
                                                                            Marcello Stein Ph.D. received his doctoral degree in immunology from the University of Erlangen-Nuremberg, Germany in 2011. After two years of post-doctoral studies at the Department of Immune Modulation at the University Hospital Erlangen, and three years as Product Manager Life Science at Peqlab Biotechnologie GmbH and VWR International AG, Dr. Stein joined Miltenyi Biotec as Global Product Manager and Group Leader Immunology T cells in the marketing department. His team focuses primarily on the T cell research product portfolio and covers amongst others workflows for CAR T cell research, antigen-specific T cells and regulatory T cells.
                                                                          • Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
                                                                            China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
                                                                            Biography
                                                                              Dr. Yi-Wei Tang is currently the China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai. He obtained his medical training from Fudan University Shanghai School of Medicine and Ph.D. in microbiology and immunology from Vanderbilt University. He was a Lecturer and Clinical Fellow at the Mayo Clinic, a Professor at the Vanderbilt University School of Medicine, Chief of the Clinical Microbiology Service at the Memorial Sloan-Kettering Cancer Center and a Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University in New York City, USA. He has been engaged in developing and evaluating new and advanced microbiological diagnostic testing procedures. Dr. Tang ranks among the top of the scientific field in clinical and molecular microbiology, as evidenced by his election as an Editor for the Journal of Clinical Microbiology, an Associate Editor for the Journal of Molecular Diagnostics, an Associate Editor for the Emerging Microbes and Infection, and a Fellow of the American Academy for Microbiology and of the Infectious Disease Society of America. Dr. Tang has been recognized for his extraordinary expertise in the molecular microbiology diagnosis and monitoring with over 200 peer-reviewed articles and over 100 book chapters in this field during the past 20 years.
                                                                            • Imad Tarhoni, MD, PhD
                                                                              Postdoctoral Fellow at Rush University Medical Center in Chicago
                                                                              Biography
                                                                                Imad Tarhoni, MD, PhD is currently a Postdoctoral Fellow at Rush University Medical Center in Chicago, Illinois, where his main research goals center on developing diagnostic tests, including those for cancer and COVD-19 related diseases. His interest for science, has been an active one, where, after earning his medical degree from the University of Zawiya in Libya and serving as physician and faculty member in the department of clinical biochemistry, his passion for pursuing a physician-scientist career path compelled him to travel to the USA to seek further professional training. In 2012 through 2019, Imad earned his Master's and PhD degrees in the laboratory of Dr. Jeffrey A. Borgia at Rush University Medical Center, where his training focused on diagnostic test development and validation in Cancer biology. Imad is also an active member of the American Society of Clinical Pathology and the American Association for Clinical Chemistry with track record scientific contributions. His long term career goal is to pursue precision medicine advancement through formal board eligible pathology training.
                                                                              • Sean Taylor
                                                                                Manager of the Field Applications Group at GenScript USA, Inc
                                                                                Biography
                                                                                  Sean Taylor holds a Ph.D. and an MBA from McGill University and has spent the past ten years publishing articles, providing seminars, workshops and training videos to help the global scientific community achieve excellent data from western blotting, qPCR and digital PCR experiments. He has managed teams of Field Application Scientists (FAS) in Canada for over a decade who have helped thousands of scientists achieve their research goals. In his current role as North American FAS Manager for GenScript, he leads a dedicated team to continue the tradition of providing pertinent and timely information to help the scientific community overcome research hurdles to accelerate the production of high quality, publishable data, cost-effectively.
                                                                                • Jeray Thelwell
                                                                                  Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
                                                                                  Biography
                                                                                    A researcher at heart, Jeray is an expert in assay development and automated liquid handling for genomic and biotherapeutic applications.
                                                                                  • Todd Treangen
                                                                                    Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
                                                                                    Biography
                                                                                      Todd J. Treangen, Ph.D. is an Assistant Professor in the Department of Computer Science at Rice University and co-lead of the COVID-19 International Research Team (COV-IRT, www.cov-irt.org). Prior to joining Rice, Dr. Treangen was an Assistant Research Professor at the University of Maryland College Park. He received his Ph.D. in Computer Science in 2008 from the Polytechnic University of Catalonia (Barcelona, Spain). His research group focuses on solving large-scale computational problems specific to computational biology, with a focus on developing robust software tools targeted towards biothreat screening, infectious disease monitoring, and microbial forensics. For more info: https://www.treangenlab.com
                                                                                    • Kamala Tyagarajan, PhD
                                                                                      Director, Flow Cytometry Assays & Application
                                                                                      Biography
                                                                                        Dr. Kamala Tyagarajan is Director, Flow Cytometry Assays and Applications at Luminex Corporation where her team is responsible for applications and assay development on Luminex's microcapillary based flow cytometry platforms. Dr. Tyagarajan was previously R&D Director, MilliporeSigma, EMD Millipore and Guava Technologies and has brought out a range of flow cytometry products for cellular health, immunology and blood-based diagnostics. Previously, Dr. Tyagarajan worked at Lynx Therapeutics (now Illumina) developing novel fluorescence- based and mass spectrometry based proteomic technologies. Kamala obtained her PhD Degree at University of California, Berkeley and postdoctoral research at UC San Francisco/UC Berkeley working on parietal cell glycobiology and proteomics.
                                                                                      • Chengbin Wang, MD
                                                                                        Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
                                                                                      • Linfa Wang, PhD
                                                                                        Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
                                                                                        Biography
                                                                                          Linfa Wang, PhD, is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore. Having completed his Bachelor's degree in 1982 at the East China Normal University in Shanghai, Wang went on to obtain his PhD at the University of California, Davis. His early research was at the Monash Centre for Molecular Biology and Medicine. In 1990, he joined the Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory (AAHL), where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. His research then extended from bat-borne viruses to bettering understanding virus-bat interaction, and he led an international team carrying out comparative genomic analysis of two bat species. They discovered an important link between adaptation to flight and bats' ability to counter DNA damage repair as a result of fast metabolism and to co-exist with a large number of viruses without developing clinical diseases. Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences and many top scientific publications, including Science, Nature, Nature Reviews in Microbiology, Lancet Infectious Diseases and the Proceedings of the National Academy of Sciences (PNAS), along with five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Wang was elected as a fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases. Wang is also active internationally by serving on various editorial boards for publication in the areas of virology, microbiology and infectious diseases. He is currently the editor-in-chief of the Virology Journal.
                                                                                        • David Wilson
                                                                                          Commercial Director, Diagnostics, Avacta Life Sciences
                                                                                          Biography
                                                                                            David brings to Avacta over 25 years international experience in business development, marketing and sales management in the in-vitro diagnostic medical devices industry, having held senior commercial and Board level positions in global corporations, angel and venture capital funded start-ups and a sector specific trade association. He is currently a Board member for two early-stage diagnostic businesses developing novel point of care diagnostic testing platforms, and has served on the Executive Committee of the British In Vitro Diagnostics Association (BIVDA). David has a BSc (Hons) in Biochemistry and Microbiology from the University of St. Andrews and a MBA from the Open University Business School.
                                                                                          • Jun Wu, PhD
                                                                                            Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
                                                                                            Biography
                                                                                              Dr. Wu is an Associate professor in Pathology, as well Vice Director of Clinical Laboratory Medicine Center at the Shanghai General Hospital which is affiliated to Shanghai Jiaotong University. He is also a Youth member of Chinese Society of Laboratory Medicine, as well as a Member of Shanghai Medical Association, Molecular Diagnostics Branch, and a Member of Chinese Expert Committee of Experimental Medicine, Pathology Branch.
                                                                                            • Frank Yang, MD, PhD
                                                                                              Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
                                                                                            • Jiahui Yang, PhD
                                                                                              Director, R&D, Sino Biological
                                                                                              Biography
                                                                                                Dr. Jiahui Yang received her PhD from Tufts University. She joined Sino Biological Inc. since 2010 and currently is the Director of R&D department. She has 10-year recombinant protein and antibody development and optimization experience. She and her team have successfully produced >3000 recombinant proteins and >5000 antibodies.
                                                                                              • Pan Zhang, PhD
                                                                                                Laboratory Director at BGI
                                                                                                Biography
                                                                                                  Pan Zhang serves as the Laboratory Director at BGI, which provides high-throughput NGS services to a wide range of customers. Prior of joining BGI, she was the Director of the Sequencing and Microarray Center at Coriell Institute for Medical Research, where she oversaw genome analyses of thousands of participants in precision medicine research studies. Before Coriell, Pan was a senior clinical research scientist at Weill Cornell Medicine New York-Presbyterian Hospital, where she was responsible for developing next-generation sequencing for clinical oncology tests in a molecular diagnostic laboratory and translational research studies. She earned her advanced degree in neuropharmacology at Beijing University Health Science Center and her medical degree at Shanxi Medical University. She acquired her doctorate in biomedical sciences from Rutgers Biomedical and Health Sciences.
                                                                                                • Susan Zolla-Pazner, PhD
                                                                                                  Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
                                                                                                  Biography
                                                                                                    Dr. Zolla-Pazner received her Bachelor's degree at Stanford University and her Ph. D. in Medical Microbiology at the University of California Medical Center in San Francisco. Her doctoral studies were focused on the immunochemistry of antibodies produced by immunization, and were a continuation of the pioneering immunochemical studies of Dr. Michael Heidelberger and Dr. Elvin Kabat. Her research made use of the sera employed for passive immunization in the treatment of pneumococcal pneumonia prior to the advent of antibiotic treatment. Dr. Zolla-Pazner's Ph. D dissertation focused on the cross-reactivity of anti-pneumococcal antibodies and the unusual isotype of antibodies present in the horse sera used for treatment of pneumonia. Having completed her doctoral training, Dr. Zolla-Pazner spent two years as a post-doctoral fellow at the NYU School of Medicine working with Dr. Edward C. Franklin. While a fellow at NYU, Dr. Zolla-Pazner's research focused on immunoglobulin synthesis by myeloma cells derived from human bone marrow biopsies. These studies led to several years of study of mouse plasmacytomas and their suppressive effects on induction of antibody responses. These early studies established her credentials as "a B cell immunologist". In 1969, Dr. Zolla-Pazner established her own laboratory at the New York Veterans Administration Hospital in Manhattan, which was and is a part of the NYU Medical Center. There, she continued her work on mouse plasmacytomas and, in 1977 she also became the Director of the Clinical Immunology Laboratory, the only lab in the NYU/VA complex to assess the function of immune responses in human patients. As a result of her Directorship of the Human Clinical Immunology lab, in 1981 Dr. Zolla-Pazner was among the first scientists to participate in the description of the immunologic abnormalities in patients with the then mysterious illness which became known as AIDS, affecting gay men, hemophiliacs and intravenous drug users. She was also responsible for providing the initial descriptions of immunologic abnormalities for the first patients with AIDS-related Mycobacterium avium-intracellulare and to identify similar immunologic abnormalities in apparently healthy gay men who went on to develop AIDS. This work established the chilling realization that 1/3 of gay men in New York City were suffering from a potentially fatal unknown illness. In these early days of the AIDS epidemic, the Zolla-Pazner lab described the hyperactivation of B lymphocytes in HIV-infected individuals, and this discovery led Dr. Zolla-Pazner to develop methods allowing the generation of anti-HIV human monoclonal antibodies (mAbs) from the cells of HIV-infected individuals. Her lab was among the first to isolate and describe human mAbs capable of neutralizing the infectivity of the virus, and later was the first lab to isolate a mAb ofgreat neutralizing potency targeting a quaternary neutralizing epitope which includes the V2 loop of the HIV envelope protein. Studies of the second and third variable loops (V2 and V3 loops) of the gp120 envelope protein contributed to an understanding of their function in virus infectivity as well as how and why V2 and V3 from diverse viruses share antigenic similarities. Using the mAbs described above, Dr. Zolla-Pazner and her colleagues have identified generic, shared structures in the V2 and V3 loops and used these to design V2- and V3-scaffold protein immunogens. Her lab has also used gp120 DNA as a priming immunogen, and recombinant "designer epitope-scaffold immunogens" to show that the immune response in rabbits and non-human primates can be focused on a single envelope epitope (V2 or V3), thus inducing antibodies which recognize diverse strains and subtypes of the virus; these antibodies have the potential of blocking infection by HIV. This body of work led to the seminal finding of the correlation between antibodies directed at the V2 loop of gp120 and the reduced risk of infection in the RV144 clinical vaccine trial, a finding that has been pivotal in establishing the central role of antibodies in protection from HIV infection and has helped to focus the HIV vaccine field on humoral immunity in preventing HIV infection. This platform for immunogen design is now being applied to the development of V2-scaffold immunogens on the basis of crystallographic studies of V2 mAbs and the V2 epitopes they target. At Mount Sinai School of Medicine, Dr. Zolla-Pazner's research continues to focus on the immunologic abnormalities in HIV infection and the development of HIV vaccine candidates. Specifically the Zolla-Pazner lab studies the production and characterization of human anti-HIV mAbs, the epitopes they target, and the immunologic and biologic properties of the variable regions of the HIV gp120 envelope glycoprotein. This information is being used to develop a prophylactic HIV vaccine. Since beginning her independent research in 1969, Dr. Zolla-Pazner has received continuous funding and served as Principle Investigator on research grants, program project grants and training grants from the NIH, Department of Veterans Affairs, US Army, and the Bill and Melinda Gates Foundation. Dr. Zolla-Pazner has published over 300 papers, many in high impact journals including Science, Journal of Infectious Diseases, Journal of Immunology, Journal of Virology, Nature Structural and Molecular Biology, and the New England Journal of Medicine. She is an elected fellow of the American Association for the Advancement of Science (AAAS) and the American Society of Microbiology (ASM), and Adjunct Professor at the Rockefeller University.
                                                                                                  Posters

                                                                                                  Posters

                                                                                                   

                                                                                                  POSTER SUBMISSION GUIDELINES

                                                                                                  Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

                                                                                                   

                                                                                                  SUBMIT YOUR ABSTRACT

                                                                                                  Enter the following information to this Submission Form:

                                                                                                  • Poster Title
                                                                                                  • Your Name
                                                                                                  • Your Institution
                                                                                                  • Your Email
                                                                                                  • Abstract describing the poster

                                                                                                   

                                                                                                  All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                                                                                  If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                                                                                  Questions? Email Posters@LabRoots.com

                                                                                                  LabRoots Policy

                                                                                                  Sponsored by

                                                                                                  For information on becoming a sponsor or exhibitor, please click here.


                                                                                                  C.E. Credits

                                                                                                  The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here